FDA Clearance Opportunity Leverage ExsoMed's FDA 510(k) clearance for the NanoPhix cannulated lag screw system to position solutions for fracture surgeries such as avulsion, mallet, and condylar fractures. Target hospitals and surgical centers expanding extremity fixation options.

Extremity Focus ExsoMed specializes in minimally invasive solutions for extremity implant procedures. Market to orthopedic departments emphasizing faster procedures, improved patient outcomes, and potential reductions in recovery time.

Education Access Utilize ExsoMed’s Mobile Training and Cadaver Lab program as a selling point to teaching hospitals and residency programs. Offer on-site training bundles that reduce learning curves and accelerate adoption of new devices.

Growth Potential With revenue in the low-to-mid seven-figure range and recent regulatory approvals, there is room for scaled adoption through physician evangelists, case-based demonstrations, and bundled procurement deals with surgical suites.

Strategic Partnerships Position ExsoMed as a partner for access to emerging markets and peer networks by aligning with key opinion leaders in hand and extremity surgery, and exploring collaborations with larger orthopedics distributors seeking innovative implants.